检测溶血磷脂酸及D-二聚体预测进展性脑卒中的临床价值  

Clinical value of detecting lysophosphatidic acid and D-dimer in predicting progressive stroke

作　　者：李艳杰[1] LI Yanjie(Shangshui County People's Hospital,Shangshui 466100,China)

机构地区：[1]商水县人民医院

出　　处：《中国实用神经疾病杂志》2019年第23期2635-2639,共5页Chinese Journal of Practical Nervous Diseases

摘　　要：目的研究D-二聚体及溶血磷脂酸(LPA)对进展性脑卒中(SIP)的诊断价值。方法选取32例进展性脑卒中患者(实验组)及32名健康体检者(对照组),测定2组研究对象的LPA和D-二聚体水平并进行对比分析。结果实验组LPA水平明显高于对照组,差异有统计学意义(P<0.05);实验组D-二聚体检验结果为阳性,对照组为阴性。结论 D-二聚体与LPA能够对SIP患者疾病变化状况做出较敏锐反应,可为临床治疗提供一定参考。Objective To study the diagnostic value of D-dimer and lysophosphatidic acid(LPA) for progressive stroke(SIP).Methods Thirty-two patients with progressive stroke and 32 healthy subjects were selected as experimental group and control group.The levels of LPA and D-dimer in the two groups were determined and compared.Results The LPA level in the experimental group was significantly higher than that in the control group,and the difference was statistically significant(P<0.05).The D-dimer test results were positive in the experimental group and negative in the control group.Conclusion D-dimer and LPA can make a more sensitive response to the disease changes of SIP patients,which can provide a reference for clinical treatment.

关 键 词：进展性脑卒中 难治性脑血管疾病 溶血磷脂酸 D-二聚体 

分 类 号：R743.3[医药卫生—神经病学与精神病学]